A recombinant single chain antibody interleukin-2 fusion protein

British Journal of Cancer

Volumn 67, Issue 2, 1993, Pages 304-310

  Savage, P ^a,b   So, A ^b   Spooner, R A ^a   Epenetos, A A ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; HYBRID PROTEIN; INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 2; RECOMBINANT PROTEIN;

ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; DRUG TARGETING; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN VARIABLE REGION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; RECOMBINANT DNA TECHNOLOGY; SIDE EFFECT;

AMINO ACID SEQUENCE; ANTIBODIES; BASE SEQUENCE; CHROMATOGRAPHY, AFFINITY; FEASIBILITY STUDIES; FLOW CYTOMETRY; HUMAN; IMMUNOGLOBULINS, HEAVY-CHAIN; IMMUNOGLOBULINS, LIGHT-CHAIN; IMMUNOTOXINS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MURAMIDASE; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; STIMULATION, CHEMICAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0027512894     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1993.57     Document Type: Article

References (27)

1. BETTER, M., WEICKMANN, J. & LIN, Y.-L. (1990). Production and scale up of chimeric Fab fragments from bacteria. ICSU Short report 10, 105. IRL press: Oxford University Press.
2. CLACKSON, T., HOOGENBOOM, H R., GRIFFITHS, A.D. & WINTER, G. (1991). Making antibody fragments using phage display libraries. Nature, 352, 624-628.
3. COLCHER, D., BIRD, R., ROSELLI, M., HARDMAN, K.D., JOHNSON, S., POPE, S., DODD, S., PANTOLIANO, M.W., MILENIC, D.E. & SCHLOM, J. (1990). In vivo tumour targeting of a recombinant single-chain antigen-binding protein. JNCI, 82, 1191-1197.
4. FEARON, E.R., PARDOLL, D.M., ITAYA, T., GOLUMBEK, P., LEVITSKY, H I., SIMONS, J.W., KARASUYAMA, H., VOGELSTEIN, B. & FROST, P. (1990). Interleukin-2 production by tumour cells bypasses T helper function in the generation of an antitumour response. Cell, 60, 397-403.
5. FELL, HP., GAYLE, M.A., GROSMAIRE, L. & LEDBETTER, J.A. (1991). Genetic construction and characterization of a fusion protein consisting of a chimeric F(ab’) with specificity for carcinomas and human IL-2. J. Immunol., 146, 2446-2452.
6. GILLIES, S.D., REILLY, E.D., LO, K.M. & REISFEL, R.A. (1992). Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells. Proc. Natl Acad. Sci. USA, 89, 1428-1432.
7. GILLIS, S., FERM, M.M., OU, W. & SMITH, K.A. (1978). T cell growth factor: parameters of production and a quantative microassay for activity. J. Immunol., 120, 2027-2032.
8. GILLIS, S. & SMITH, K.A. (1977). Long term culture of tumour-specific cytotoxic T cells. Nature, 268, 154-156.
9. HENNIGAN, T.W., BEGENT, R.H.J. & ALLEN-MERSH, T.G. (1991). Histamine, leukotriene C4 and interleukin-2 increase antibody uptake into a human carcinoma xenograft model. Br. J. Cancer., 64, 872-874.
10. HUSTON, J.S., LEVINSON, D., MUDGETT-HUNTER, M., TAI, M.-S., NOVOTNY, J., MARGOLIES, M.N., RIDGE, R.J., BRUCCOLERI, R E., HABER, E., CREA, R. & OPPERMAN, H. (1988). Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA, 85, 5879-5883.
11. KIYOKAWA, T., WILLIAMS, D.P., SNIDER, C.E., STROM, T.B. & MURPHYS, J.R. (1991). Protein engineering of diptheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high affinity IL-2-receptor bearing target cells. Prot. Eng in., 4, 463-468.
12. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
13. LANDOLF, N.F. (1991). A chimeric IL-2/Ig molecule possesses the functional activity of both proteins. J. Immunol., 146, 915-919.
14. LEBERTHON, B., KHAWLI, L.A., ALAUDDIN, M., MILLER, G.K., CHARAK, B.S., MASUMDER, A. & EPSTEIN, A.L. (1991). Enhanced tumour uptake of macromolecules induced by a novel vasoactive interleukin-2 immunoconjugate. Cancer Res., 51, 2694-2698.
15. LEI, S P., LIN, H.C., WANG, S.S., CALLAWAY, J. & WILCOX, G. (1987). Characterization of the Erwinia carotovora pelB gene and its product pectate lyase. J. Bact., 169, 4379-4383.
16. LORDERBOUM-GALSKI, H., FITZGERALD, D., CHAUDARY, V., ALDHAYA, S. & PASTAN, I. (1988). Cytotoxic activity of an interleukin-2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli. Proc. Natl Acad. Sci. USA, 85, 1922-1926.
17. LOTZE, M.T., CHANG, A.G., SEIPP, C.A., SIMPSON, C., VETTO, J.T. & ROSENBERG, S.A. (1986). High dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. J. Am. Assoc., 256, 3117-3124.
18. MARKS, J.D., HOOGENBOOM, H.R., BONNERT, T.P., MCCAFFERTY, J., GRIFFITH, D. & WINTER, G. (1991). By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol., 222, 581-597.
19. MCCAFFERTY, J., GRIFFITHS, A.D., WINTER, G. & CHISWELL, D.J. (1990). Phage antibodies: filamentous phage displaying antibody variable domains. Nature, 348, 552-554.
20. ROSENBERG, S.A., LOTZE, M.T., YANG, J A., AEBERSOLD, P.M., LINEHAN, W.M., SEIPP, C.A. & WHITE, D.E. (1989). Experience with the use of high dose interleukin-2 in the treatment of 652 cancer patients. Ann. Surg., 210, 474-485.
21. SAVAGE, P.M., BEYNON, H.C., SO, A., WALPORT, M.J. & EPENETOS, A.A. (1993). The single chain antibody interleukin-2 fusion protein mimics the effects of rIL-2 on endothelial cell permeability (submitted).
22. SMITH, K.A., FAVATA, M.F. & OROSZLAN, S. (1983). Production and characterization of monoclonal antibodies to human interleukin-2: strategy and tactics. J. Immunol., 131, 1808-1815.
23. STAUCH, K.L., JOHNSON, K. & BECKWITH, J. (1989). Characterization of degP: a gene required for proteolysis in the cell envelope and essential for growth of Escherichia coli at high temperature. J. Bact., 171, 2689-2696.
24. TOWBIN, H., STAEHELIN, T. & GORDON, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA, 76, 4350-4354.
25. WARD, E.S., GUSSOW, D., GRIFFITHS, A.D., JONES, P.T. & WINTER, G. (1989). Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature, 341, 544-546.
26. WILLIAMS, D.P., PARKER, K., BACHA, P., BISHAI, W., BOROWSKI, M., GENBAUFFE, F., STROM, T.B. & MURPHY, J.R. (1987). Diptheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diptheria toxin-related interleukin-2 fusion protein. Prot. Engin., 1, 493-498.
27. YOKOTA, T., MILENIC, D.E., WHITLOW, M. & SCHLOM, J. (1992). Rapid tumour penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res., 52, 3402-3408.